Purchase Order 75F40120P00078

Award Date 2/13/20
Potential Completion Date 8/2/26
Potential Value $323K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
1077 Ashford Ave, San Juan, 00907, Puerto Rico
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $169,582.98 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division to deliver three ultraviolet-visible spectrometers. The place of performance is Marshallton, Delaware and the period of performance spans from September 2023 through November 2028. As the prime contractor, Agilent Technologies will provide the requested analytical instrumentation to support the FDA's...
This federal contract award, valued at $99,438.48, was issued by the Food and Drug Administration (FDA) to Agilent Technologies Inc. for the delivery of a handheld Raman device that uses an 830 nm laser. The device is designed to strike the proper balance of fluorescence mitigation and Raman activity for FDA applications, and its SORS optics allow it to scan through dark, thick, colored, and opaque layers. This is a firm fixed-price purchase order contract with a completion date of September...
The Food and Drug Administration (FDA) awarded a $96,929.40 firm-fixed-price purchase order to Agilent Technologies Inc. to provide three dissolution apparatus systems with sampling units, temperature probes, vessels, and other accessories. The FDA's Division of Product Quality Research has a requirement for this specialized laboratory equipment. The contract has an ultimate completion date of May 14, 2022 and was awarded on April 13, 2021. This purchase order is not associated with a...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a Firm Fixed Price purchase order to Agilent Technologies Inc. Customer Service And Sales Division to acquire a brand-specific Agilent fully automated dissolution system. The system will include a UV-VIS detector, filter module, and integrated software to support the work of the Detroit Laboratory (DETL). The potential value of the contract is $242,162.37, with a completion date of September 28, 2023....
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order to Agilent Technologies Inc., Customer Service and Sales Division, for a preventive maintenance agreement on a Rapid Fire 365 system. The $120,816.00 contract has a completion date of July 14, 2026 and does not utilize a set-aside. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing laboratories with instruments,...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Agilent Technologies, Inc. for the acquisition of a triple quadrupole mass spectrometer with gas chromatograph. The contract has a potential value of $305,252.53 and a completion date of October 8, 2022. This award does not have a set-aside designation. Agilent Technologies, a global leader in life sciences and diagnostics, has previously served as a prime contractor and...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc. The $113,616.84 purchase order is for a firm fixed price contract with a completion date of November 18, 2022. The contract does not have a set-aside designation. Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical markets, providing...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc., for the purchase of a Cell Imaging Multi-Mode Reader (UPRIGHT + INVT MICR MULTI-MODE RDR, PART # CYT7UMW-S) and accessories. The potential value of the contract is $229,568.51 with a completion date of October 16, 2027. This purchase order was awarded on August 1, 2022...
This $822,112.13 firm fixed price delivery order was awarded by the Food and Drug Administration (FDA) to Agilent Technologies Inc. (Agilent) on April 19, 2016 under the General Services Administration (GSA) Schedule 66 for Scientific Equipment and Services. The contract is for the delivery of a high resolution ion mobility quadrupole time-of-flight (QTOF) system to support research at the FDA. Agilent is a global leader in life sciences, diagnostics, and applied chemical markets, providing...
The Department of Health and Human Services Food and Drug Administration awarded a $66,521 delivery order against the Agilent Technologies Inc. Customer Service And Sales Division Multiple Award Schedule contract. Under this firm fixed price order, Agilent will provide a preparative-scale high performance liquid chromatography system to the FDA's Marshallton, Delaware facility between September 2023 and January 2025. As the regulatory agency responsible for ensuring the safety and...

The Department of Health and Human Services Food and Drug Administration awarded a $323,129.68 firm fixed price purchase order to Agilent Technologies Inc. for a laser direct infrared imaging system to support compositional analysis of pharmaceutical products. The solicitation sought a system with capabilities including spectral matching, co-aligned visible and infrared images, and sample sizes up to 75mm to assist FDA in its regulatory responsibilities. Agilent Technologies will deliver the requested laser direct infrared chemical imaging system over a 6-year period of performance ending August 2026 for use at FDA facilities in Puerto Rico. No subcontractors or set-aside designation were identified. This purchase supports FDA's mission to protect and promote public health through regulatory oversight and analysis of pharmaceutical products.

Generated 12/29/23, 4:34 PM